Browse by UCL people
Group by: Type | Date
Number of items: 74.
Article
Abdel-Mannan, Omar;
Champsas, Dimitrios;
Tur, Carmen;
Lee, Vanessa;
Manivannan, Sharmila;
Usman, Haroon;
Skippen, Alison;
... UK-Childhood Neuroinflammatory Disease Network; + view all
(2023)
Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2023-332542.
(In press).
|
Abdel-Mannan, OA;
Manchoon, C;
Rossor, T;
Southin, J-C;
Tur, C;
Brownlee, W;
Byrne, S;
... UK-Childhood Inflammatory Disease Network, .; + view all
(2021)
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Neurology: Neuroimmunology and NeuroInflammation
, 8
(4)
10.1212/NXI.0000000000001008.
|
Alexander, Sarah;
Braisher, Marie;
Tur, Carmen;
Chataway, Jeremy;
(2022)
The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis.
Multiple Sclerosis Journal
, 28
(14)
pp. 2285-2293.
10.1177/13524585221124043.
|
Arrambide, G;
Espejo, C;
Eixarch, H;
Villar, LM;
Alvarez-Cermeno, JC;
Picon, C;
Kuhle, J;
... Tintore, M; + view all
(2016)
Neurofilament light chain level is a weak risk factor for the development of MS.
Neurology
, 87
(11)
pp. 1076-1084.
10.1212/WNL.0000000000003085.
|
Arrambide, G;
Iacobaeus, E;
Amato, MP;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Brundin, L;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (2): Treatment.
Multiple Sclerosis Journal
, 26
(9)
pp. 1045-1063.
10.1177/1352458520924595.
|
Arrambide, G;
Rovira, A;
Sastre-Garriga, J;
Tur, C;
Castillo, J;
Rio, J;
Vidal-Jordana, A;
... Tintore, M; + view all
(2018)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
Multiple Sclerosis Journal
, 24
(3)
pp. 301-312.
10.1177/1352458517697830.
|
Bianchi, Alessia;
Cortese, Rosa;
Prados, Ferran;
Tur, Carmen;
Kanber, Baris;
Yiannakas, Marios C;
Samson, Rebecca;
... Toosy, Ahmed T; + view all
(2024)
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein–associated disease.
Multiple Sclerosis Journal
, 30
(6)
674 -686.
10.1177/13524585241240420.
|
Bichuetti, DB;
Franco, CA;
Elias, I;
Mendonca, ACR;
Diniz Carvalho, LF;
Diniz, DS;
Tur, C;
... Lobato de Oliveira, EM; + view all
(2018)
Multiple sclerosis risk perception and acceptance for Brazilian patients.
Arquivos de Neuro-Psiquiatria
, 76
(1)
pp. 6-12.
10.1590/0004-282X20170167.
|
Brownlee, Wallace J;
Tur, Carmen;
Manole, Andreea;
Eshaghi, Arman;
Prados, Ferran;
Miszkiel, Katherine A;
Wheeler-Kingshott, Claudia Am Gandini;
... Ciccarelli, Olga; + view all
(2022)
HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis.
Multiple Sclerosis Journal
10.1177/13524585221130941.
(In press).
|
|
Brownlee, WJ;
Miszkiel, KA;
Tur, C;
Barkhof, F;
Miller, DH;
Ciccarelli, O;
(2018)
Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.
Neurology
, 91
(12)
e1130-e1134.
10.1212/WNL.0000000000006207.
|
Calvi, Alberto;
Carrasco, Ferran Prados;
Tur, Carmen;
Chard, Declan T;
Stutters, Jonathan;
De Angelis, Floriana;
John, Nevin;
... MSSMART Investigators, .; + view all
(2022)
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.
Neurology
, 98
(17)
e1783-e1793.
10.1212/WNL.0000000000200144.
|
Calvi, Alberto;
Clarke, Margareta A;
Prados, Ferran;
Chard, Declan;
Ciccarelli, Olga;
Alberich, Manel;
Pareto, Deborah;
... Barkhof, Frederik; + view all
(2022)
Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis.
Multiple Sclerosis Journal
10.1177/13524585221141964.
(In press).
|
Calvi, A;
Haider, L;
Prados, F;
Tur, C;
Chard, D;
Barkhof, F;
(2020)
In vivo imaging of chronic active lesions in multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458520958589.
(In press).
|
Cawley, N;
Solanky, BS;
Muhlert, N;
Tur, C;
Edden, RA;
Wheeler-Kingshott, CA;
Miller, DH;
... Ciccarelli, O; + view all
(2015)
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Brain
, 138
(9)
pp. 2584-2595.
10.1093/brain/awv209.
|
Cawley, N;
Tur, C;
Prados, F;
(2017)
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis (vol 23, pg 1, 2017).
[Corrigendum].
Multiple Sclerosis Journal
, 23
(13)
NP30-NP30.
10.1177/1352458517717937.
|
Cawley, N;
Tur Gomez, C;
Prados Carrasco, F;
Plantone, D;
Kearney, H;
Abdel-Aziz, K;
Ourselin, S;
... Ciccarelli, O; + view all
(2017)
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
Multiple Sclerosis
10.1177/1352458517709954.
(In press).
|
Charalambous, T;
Clayden, JD;
Powell, E;
Prados, F;
Tur, C;
Kanber, B;
Chard, D;
... Toosy, AT; + view all
(2020)
Disrupted principal network organisation in multiple sclerosis relates to disability.
Scientific Reports
, 10
, Article 3620. 10.1038/s41598-020-60611-4.
|
Charalambous, T;
Tur, C;
Prados, F;
Kanber, B;
Chard, DT;
Ourselin, S;
Clayden, JD;
... Toosy, AT; + view all
(2019)
Structural network disruption markers explain disability in multiple sclerosis.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(2)
pp. 219-226.
10.1136/jnnp-2018-318440.
|
Chard, DT;
Alahmadi, AAS;
Audoin, B;
Charalambous, T;
Enzinger, C;
Hulst, HE;
Rocca, MA;
... MAGNIMS Study Group, .; + view all
(2021)
Mind the gap: from neurons to networks to outcomes in multiple sclerosis.
Nature Reviews Neurology
, 17
pp. 173-184.
10.1038/s41582-020-00439-8.
|
Ciampi, E;
Pareto, D;
Sastre-Garriga, J;
Vidal-Jordana, A;
Tur, C;
Rio, J;
Tintore, M;
... Montalban, X; + view all
(2017)
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Multiple Sclerosis Journal
, 23
(4)
pp. 556-566.
10.1177/1352458516656808.
|
Ciccarelli, Olga;
Barkhof, Frederik;
Calabrese, Massimiliano;
De Stefano, Nicola;
Eshaghi, Arman;
Filippi, Massimo;
Gasperini, Claudio;
... Toosy, Ahmed T; + view all
(2024)
Using the Progression Independent of Relapse Activity
Framework to Unveil the Pathobiological Foundations
of Multiple Sclerosis.
Neurology
, 103
(1)
, Article e209444. 10.1212/WNL.0000000000209444.
|
Colato, E;
Stutters, J;
Tur, C;
Narayanan, S;
Arnold, DL;
Gandini Wheeler-Kingshott, CAM;
Barkhof, F;
... Eshaghi, A; + view all
(2021)
Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325610.
(In press).
|
Collorone, Sara;
Coll, Llucia;
Lorenzi, Marco;
Lladó, Xavier;
Sastre-Garriga, Jaume;
Tintoré, Mar;
Montalban, Xavier;
... Tur, Carmen; + view all
(2024)
Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis.
Multiple Sclerosis Journal
, 30
(7)
767 - 784.
10.1177/13524585241249422.
|
Collorone, S;
Prados, F;
Hagens, MH;
Tur, C;
Kanber, B;
Sudre, CH;
Lukas, C;
... MAGNIMS Study Group, .; + view all
(2019)
Single-subject structural cortical networks in clinically isolated syndrome.
Multiple Sclerosis Journal
10.1177/1352458519865739.
(In press).
|
Cortese, Rosa;
Carrasco, Ferran Prados;
Tur, Carmen;
Bianchi, Alessia;
Brownlee, Wallace;
De Angelis, Floriana;
De La Paz, Isabel;
... Ciccarelli, Olga; + view all
(2022)
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Neurology
10.1212/WNL.0000000000201465.
(In press).
|
Cortese, R;
Magnollay, L;
Tur Gomez, C;
Abdel-Aziz, K;
Jacob, A;
De Angelis, F;
Yiannakas, MC;
... Ciccarelli, O; + view all
(2018)
The value of the central vein sign at 3T to differentiate MS from seropositive-NMOSD.
Neurology
, 90
(14)
e1183-e1190.
10.1212/WNL.0000000000005256.
|
Cortese, R;
Tur, C;
Prados, F;
Schneider, T;
Kanber, B;
Moccia, M;
Wheeler-Kingshott, CAMG;
... Ciccarelli, O; + view all
(2020)
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458519900971.
(In press).
|
De Pablo-Fernandez, Eduardo;
Tur, Carmen;
Revesz, Tamas;
Lees, AJ;
Holton, JL;
Warner, TT;
(2017)
Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.
JAMA Neurology
, 74
(8)
pp. 970-976.
10.1001/jamaneurol.2017.1125.
|
Eshaghi, A;
Marinescu, RV;
Young, AL;
Firth, NC;
Prados Carrasco, F;
Cardoso, MJ;
Tur Gomez, C;
... MAGNIMS Study Group, .; + view all
(2018)
Progression of regional grey matter atrophy in multiple sclerosis.
Brain
, 141
(6)
pp. 1665-1677.
10.1093/brain/awy088.
|
Eshaghi, A;
Prados Carrasco, F;
Brownlee, W;
Altmann, DR;
Tur Gomez, C;
Cardoso, MJ;
de Angelis, F;
... Ciccarelli, O; + view all
(2018)
Deep grey matter volume loss drives disability worsening in multiple sclerosis.
Annals of Neurology
, 83
(2)
pp. 210-222.
10.1002/ana.25145.
|
Gomez, C;
Kanber, B;
Eshaghi, A;
Altmann, DR;
Khaleeli, Z;
Prados Carrasco, F;
Ourselin, S;
... Ciccarelli, O; + view all
(2020)
Clinical relevance of cortical network dynamics in early primary progressive MS.
Multiple Sclerosis Journal
, 26
(4)
pp. 442-456.
10.1177/1352458519831400.
|
Grussu, F;
Ianus, A;
Tur Gomez, C;
Prados Carrasco, F;
Schneider, T;
Kaden, E;
Ourselin, S;
... Wheeler-Kingshott, C; + view all
(2018)
Relevance of time-dependence for clinically viable diffusion imaging of the spinal cord.
Magnetic Resonance in Medicine
10.1002/mrm.27463.
|
Grussu, F;
Schneider, T;
Tur, C;
Yates, RL;
Tachrount, M;
Ianuş, A;
Yiannakas, MC;
... Gandini Wheeler-Kingshott, CAM; + view all
(2017)
Neurite dispersion: A new marker of multiple sclerosis spinal cord pathology?
Annals of Clinical and Translational Neurology
, 4
(9)
pp. 663-679.
10.1002/acn3.445.
|
Grussu, F;
Schneider, T;
Yates, RL;
Tachrount, M;
Tur, C;
Newcombe, J;
Zhang, H;
... Wheeler-Kingshott, CAM; + view all
(2015)
Quantitative histological validation of NODDI MRI indices of neurite morphology in multiple sclerosis spinal cord.
Multiple Sclerosis Journal
, 21
(S11)
pp. 204-205.
10.1177/1352458515602642.
|
Haider, L;
Chung, KK;
Birch, G;
Eshaghi, A;
Mangesius, S;
Prados Carrasco, F;
Tur Gomez, C;
... Chard, DT; + view all
(2021)
Linear brain atrophy measures in multiple sclerosis and clinically isolated syndromes: A 30-year follow-up.
Journal of Neurology, Neurosurgery & Psychiatry
, 92
(8)
pp. 839-846.
10.1136/jnnp-2020-325421.
|
Iacobaeus, E;
Arrambide, G;
Pia Amato, M;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Tintore, M;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Multiple Sclerosis Journal
, 26
(9)
pp. 1031-1044.
10.1177/1352458520925369.
|
James, E;
Young, CA;
Gibbons, EL;
Shueb, A;
Tur, C;
(2020)
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis.
Cochrane Database of Systematic Reviews
, 2020
(4)
, Article CD013599. 10.1002/14651858.CD013599.
|
Kalincik, T;
Sormani, MP;
Tur, C;
(2021)
Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
Neurology
, 96
(1)
pp. 12-13.
10.1212/WNL.0000000000011120.
|
Kanber, B;
Nachev, P;
Barkhof, F;
Calvi, A;
Cardoso, M;
Cortese, R;
Prados Carrasco, F;
... Ciccarelli, O; + view all
(2019)
High-dimensional detection of imaging response to treatment in multiple sclerosis.
npj Digital Medicine
, 2
, Article 49. 10.1038/s41746-019-0127-8.
|
Kim, M;
Kujawa, A;
Battiston, M;
Demetriou, E;
Schneider, T;
Collorone, S;
Tur, C;
... Golay, X; + view all
(2020)
Translating pH‐sensitive PROgressive saturation for QUantifying Exchange rates using Saturation Times (PRO‐QUEST) MRI to a 3T clinical scanner.
Magnetic Resonance in Medicine
, 84
(4)
pp. 1734-1746.
10.1002/mrm.28229.
|
Lageman, Senne B;
Jolly, Amy;
Sahi, Nitin;
Prados, Ferran;
Kanber, Baris;
Eshaghi, Arman;
Tur, Carmen;
... Chard, Declan T; + view all
(2025)
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis.
Journal of Neurology
, 272
(2)
, Article 142. 10.1007/s00415-024-12795-2.
|
Magnollay, L;
De Angelis, F;
Wottschel, V;
Toosy, A;
Tur, C;
Yiannakas, M;
Cortese, R;
... Ciccarelli, O; + view all
(2015)
Can optic nerve MTR and OCT distinguish between multiple sclerosis and neuromyelitis optica?
Multiple Sclerosis Journal
, 21
(S11)
pp. 346-347.
10.1177/1352458515602642.
|
Rio, J;
Rovira, A;
Tintore, M;
Otero-Romero, S;
Comabella, M;
Vidal-Jordana, A;
Galan, I;
... Montalban, X; + view all
(2018)
Disability progression markers over 6-12 years in interferon-beta-treated multiple sclerosis patients.
Multiple Sclerosis Journal
, 24
(3)
pp. 322-330.
10.1177/1352458517698052.
|
Solanky, BS;
Prados, F;
Tur, C;
Yiannakas, MC;
Kanber, B;
Cawley, N;
Brownlee, W;
... Gandini Wheeler-Kingshott, CAM; + view all
(2020)
Sodium in the Relapsing–Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue Anisotropy.
Journal of Magnetic Resonance Imaging
10.1002/jmri.27201.
(In press).
|
Sormani, MP;
Tur, C;
Barkhof, F;
(2021)
Ibudilast: a paradigm shift for progressive MS?
Neurology
, 96
(4)
pp. 141-142.
10.1212/WNL.0000000000011312.
|
Thust, SC;
Hassanein, S;
Bisdas, S;
Rees, JH;
Hyare, H;
Maynard, JA;
Brandner, S;
... Mancini, L; + view all
(2018)
Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
European Radiology
, 28
(9)
pp. 3779-3788.
10.1007/s00330-018-5351-0.
|
Tintore, M;
Arrambide, G;
Otero-Romero, S;
Carbonell-Mirabent, P;
Rio, J;
Tur, C;
Comabella, M;
... Montalban, X; + view all
(2019)
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
Multiple Sclerosis Journal
10.1177/1352458519877810.
(In press).
|
|
Tintore, M;
Otero-Romero, S;
Rio, J;
Arrambide, G;
Pujal, B;
Tur, C;
Galan, I;
... Montalban, X; + view all
(2016)
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
Neurology
, 87
(13)
pp. 1368-1374.
10.1212/WNL.0000000000003144.
|
Tur, C;
Grussu, F;
De Angelis, F;
Prados, F;
Kanber, B;
Calvi, A;
Eshaghi, A;
... Gandini Wheeler-Kingshott, CAM; + view all
(2021)
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique.
NeuroImage: Clinical
, 33
, Article 102904. 10.1016/j.nicl.2021.102904.
|
Tur, Carmen;
Battiston, Marco;
Yiannakas, Marios C;
Collorone, Sara;
Calvi, Alberto;
Prados, Ferran;
Kanber, Baris;
... Wheeler-Kingshott, Claudia AM Gandini; + view all
(2024)
What contributes to disability in progressive MS? A brain and cervical cord–matched quantitative MRI study.
Multiple Sclerosis Journal
10.1177/13524585241229969.
(In press).
|
Tur, C;
(2016)
Fatigue Management in Multiple Sclerosis approach.
Current Treatment Options in Neurology
, 18
(6)
, Article 26. 10.1007/s11940-016-0411-8.
|
Tur, C;
Eshaghi, A;
Altmann, DR;
Jenkins, TM;
Prados, F;
Grussu, F;
Charalambous, T;
... Toosy, AT; + view all
(2018)
Structural cortical network reorganization associated with early conversion to multiple sclerosis.
Scientific Reports
, 8
, Article 10715. 10.1038/s41598-018-29017-1.
|
Tur, C;
Eshaghi, A;
Jenkins, TM;
Prados, F;
Clayden, JD;
Ourselin, S;
Altmann, DR;
... Toosy, AT; + view all
(2016)
Longitudinal changes in structural cortical networks after clinically isolated syndrome.
European Journal of Neurology
, 23
(S2)
, Article O1122. 10.1111/ene.13091.
|
Tur, C;
Goodkin, O;
Altmann, DR;
Jenkins, TM;
Miszkiel, K;
Mirigliani, A;
Fini, C;
... Toosy, AT; + view all
(2016)
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Brain
, 139
(3)
pp. 816-828.
10.1093/brain/awv396.
|
Tur, C;
Grussu, F;
Prados Carrasco, F;
Charalambous, T;
Collorone, S;
Kanber, B;
Cawley, N;
... Ciccarelli, O; + view all
(2019)
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458519845105.
(In press).
|
|
Tur, C;
Kalincik, T;
Oh, J;
Sormani, MP;
Tintoré, M;
Butzkueven, H;
Montalban, X;
(2019)
Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.
Neurology
10.1212/WNL.0000000000008319.
(In press).
|
Tur, C;
Moccia, M;
Barkhof, F;
Chataway, J;
Sastre-Garriga, J;
Thompson, AJ;
Ciccarelli, O;
(2018)
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.
Nature Reviews Neurology
, 14
pp. 75-93.
10.1038/nrneurol.2017.171.
|
|
Tur, C;
Thompson, AJ;
(2015)
Early accurate diagnosis crucial in multiple sclerosis.
Practitioner
, 259
(1785)
pp. 21-27.
|
Tur, C;
Wheeler-Kingshott, CA;
Altmann, DR;
Miller, DH;
Thompson, AJ;
Ciccarelli, O;
(2014)
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Human Brain Mapping
, 35
(3)
993 - 1003.
10.1002/hbm.22229.
|
Tur Gomez, C;
Montalban, X;
(2017)
Progressive MS trials: Lessons learned.
Multiple Sclerosis Journal
, 23
(12)
pp. 1583-1592.
10.1177/1352458517729460.
|
Vidal-Jordana, A;
Sastre-Garriga, J;
Pareto, D;
Tur, C;
Arrambide, G;
Otero-Romero, S;
Huerga, E;
... Montalban, X; + view all
(2018)
Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.
Multiple Sclerosis Journal
, 24
(6)
pp. 721-727.
10.1177/1352458517707070.
|
Yaldizli, Ö;
Sethi, V;
Pardini, M;
Tur, C;
Mok, KY;
Muhlert, N;
Liu, Z;
... Chard, DT; + view all
(2018)
Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 19
pp. 168-170.
10.1016/j.msard.2016.08.006.
|
Yaldizli, Ö;
Sethi, V;
Pardini, M;
Tur, C;
Mok, KY;
Muhlert, N;
Liu, Z;
... Chard, DT; + view all
(2016)
HLA-DRB∗1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 7
pp. 47-52.
10.1016/j.msard.2016.03.003.
|
Yiannakas, MC;
Mustafa, AM;
De Leener, B;
Kearney, H;
Tur, C;
Altmann, DR;
De Angelis, F;
... Gandini Wheeler-Kingshott, CAM; + view all
(2016)
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis.
NeuroImage: Clinical
, 10
pp. 71-77.
10.1016/j.nicl.2015.11.001.
|
Proceedings paper
Battiston, M;
Schneider, T;
Grussu, F;
Schenk, GJ;
Wergeland, S;
Tachrount, M;
Yiannakas, M;
... Samson, R; + view all
(2018)
Are we seeing any better? A comprehensive comparison of myelin biomarkers in the healthy and multiple sclerosis post mortem spinal cord.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
ISMRM: Paris, France.
|
|
Charalambous, T;
Prados Carrasco, F;
Tur Gomez, C;
Kanber, B;
Ourselin, S;
Chard, D;
Clayden, JD;
... Toosy, A; + view all
(2018)
Longitudinal Analysis Framework of DWI Data for Reconstructing Structural Brain Networks with Application to Multiple Sclerosis.
In: Kaden, E and Grussu, F and Ning, L and Tax, CMW and Veraart, J, (eds.)
Computational Diffusion MRI.
(pp. pp. 205-218).
Springer: Cham, Switzerland.
|
Cortese, R;
Magnollay, L;
De Angelis, F;
Prados Carrasco, F;
Grussu, F;
Tur Gomez, C;
Yiannakas, M;
... Ciccarelli, O; + view all
(2016)
No differences in spinal cord DTI abnormalilties between neuromyelitis optica spectrum disorder and multiple sclerosis.
In:
(Proceedings) ECTRIMS 2016: 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 14 - 17 September 2016, London, UK.
European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS): Basel, Switzerland.
|
Grussu, F;
Schneider, T;
Prados, F;
Tur, C;
Ourselin, S;
Zhang, H;
Alexander, D;
(2016)
Axon diameter distribution influences diffusion-derived axonal density estimation in the human spinal cord: in silico and in vivo evidence.
In:
Proceedings of the ISMRM 24th Annual Meeting & Exhibition.
International Society for Magnetic Resonance in Medicine (ISMRM): Singapore.
|
Kim, M;
Battiston, M;
Demetriou, E;
Kujawa, A;
Schneider, T;
Evans, V;
Okuchi, S;
... Golay, X; + view all
(2019)
Translating pH-sensitive PROgressive saturation for Quantifying Exchange using Saturation Times (PRO-QUEST) MRI to a 3T Clinical Scanner.
In:
Proceedings of the ISMRM 27th Annual Meeting & Exhibition.
International Society for Magnetic Resonance in Medicine (ISMRM): Montréal, Canada.
|
Tur, C;
Marschallinger, R;
Prados, F;
Collorone, S;
Altmann, DR;
Ourselin, S;
Wheeler-Kingshott, CAM;
(2018)
Linking macrostructural and microstructural damage in early MS: a geostatistical and diffusion MRI study.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
(pp. 0090).
ISMRM: Paris, France.
|
Conference item
Alahmadi, A;
Tur Gomez, C;
Pardini, M;
Zeidman, P;
Samson, R;
D'Angelo, E;
Toosy, A;
... Wheeler-Kingshott, CAM; + view all
(2016)
Disruption of functional connectivity of M1 and cerebellum in Multiple sclerosis: a long-range functional dysconnection?
Presented at: ISMRM 24th Annual Meeting & Exhibition 2016, Singapore.
|
Poster
Ananthavarathan, Piriyankan;
Sahi, Nitin;
Chung, Karen;
Prados, Ferran;
Trip, Anand;
Ciccarelli, Olga;
Barkhof, Frederik;
... Chard, Declan; + view all
(2023)
Do early predictive factors of MS clinical outcomes have a sustained effect over time?
Presented at: 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, Italy.
|
Bianchi, A;
Cortese, R;
Prados, F;
Tur, C;
Kanber, B;
Yiannakas, M;
De Angelis, F;
... Toosy, A; + view all
(2020)
Optic chiasm involvement in ms, aquaporin-4 antibody-positive nmosd, and mog antibody-associated disease.
Presented at: 8th Joint ACTRIMS-ECTRIMS Meeting, Virtual conference.
|
|
Tur, C;
Eshaghi, A;
Jenkins, TM;
Prados, F;
Clayden, JD;
Ourselin, S;
Altmann, DR;
... Toosy, AT; + view all
(2016)
Longitudinal changes in structural cortical networks after clinically isolated syndrome.
Presented at: 22nd Annual Meeting of the Organization for Human Brain Mapping, Geneva, Switzerland.
|